scholarly journals Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia

2004 ◽  
Vol 165 (3) ◽  
pp. 433-445 ◽  
Author(s):  
Mitsuru Horiki ◽  
Takeshi Imamura ◽  
Mina Okamoto ◽  
Makoto Hayashi ◽  
Junko Murai ◽  
...  

Biochemical experiments have shown that Smad6 and Smad ubiquitin regulatory factor 1 (Smurf1) block the signal transduction of bone morphogenetic proteins (BMPs). However, their in vivo functions are largely unknown. Here, we generated transgenic mice overexpressing Smad6 in chondrocytes. Smad6 transgenic mice showed postnatal dwarfism with osteopenia and inhibition of Smad1/5/8 phosphorylation in chondrocytes. Endochondral ossification during development in these mice was associated with almost normal chondrocyte proliferation, significantly delayed chondrocyte hypertrophy, and thin trabecular bone. The reduced population of hypertrophic chondrocytes after birth seemed to be related to impaired bone growth and formation. Organ culture of cartilage rudiments showed that chondrocyte hypertrophy induced by BMP2 was inhibited in cartilage prepared from Smad6 transgenic mice. We then generated transgenic mice overexpressing Smurf1 in chondrocytes. Abnormalities were undetectable in Smurf1 transgenic mice. Mating Smad6 and Smurf1 transgenic mice produced double-transgenic pups with more delayed endochondral ossification than Smad6 transgenic mice. These results provided evidence that Smurf1 supports Smad6 function in vivo.

2011 ◽  
Vol 493-494 ◽  
pp. 808-812
Author(s):  
K. Ito ◽  
Masaru Murata ◽  
J. Hino ◽  
Junichi Tazaki ◽  
T. Akazawa ◽  
...  

Body fluid permeability and blood compatibility of biomaterials are especially critical properties for regenerative bone therapy [1, 2]. To have a role in bone repair, biomaterials must have the adsorptive performance of various bone growth factors. The bone-inductive property of rabbit dentin was discovered in 1967 [3]. In our previous study, we have been researching the autograft of human demineralized dentin matrices (DDM) as a clinical study [4]. DDM is an acid-insoluble collagenous material. On the other hand, hydroxyapatite (HAp) is a mineralized material. Commercially available HAp block (APACERAM-AX®,85%-porosity with micropore) has been used as the artificial biomaterial in bone therapy [5]. Bone morphogenetic proteins (BMPs) are the strong hard tissue-inducing factors [6]. In this study, we investigated the existence of BMP-2 and -7, among proteins adsorbed to DDM and HAp, using immunoblottong analyses. The DDM granules and HAp blocks (64mm3) were implanted subcutaneously in 8-week-old Wistar rats, and sacrificed at 2 days after the implantation. Explanted DDM and HAp were homogenized by the ultrasonic procedure in phosphate-buffered saline (PBS) and the adsorbed proteins were separated on a 5-20% sodium dodecyl sulphate (SDS) polyacrylamide gradient gel by electrophoresis. For Western blotting, proteins in the gel were transferred to a polyvinylidene difluoride membrane and detected by anti-BMP-2 monoclonal antibody and anti-BMP-7 monoclonal antibody. BMP-2 and BMP-7 were detected as a major band at 50 kDa among proteins collected from the in vivo implanted DDM and HAp. BMP-2 was detected the second major band at 125 kDa in HAp and both BMP-2 and BMP-7 were detected the some minor bands in DDM and HAp. The bands of BMP-2 were stronger than those of BMP-7 in all. The DDM and HAp adsorbed BMP-2 and BMP-7. These results indicate that DDM is a useful bone substitute as much as HAp, adsorbed to the bone-inducing factors, in the bone engineering field.


Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 3679-3679
Author(s):  
Jacqueline Roy ◽  
Angela Epp ◽  
Junli Feng ◽  
Sandra Ziegler ◽  
Radek C. Skoda ◽  
...  

Abstract Thrombopoietin (TPO) and its cognate receptor c-Mpl are the primary regulators of megakaryopoiesis, and signaling through c-Mpl is necessary for maintaining normal platelet production in vivo. This signaling pathway is also critical for hematopoietic stem cell (HSC) survival and proliferation. Thrombopoietin-mediated Mpl dimerization results in phosphorylation of tyrosine residues in the c-Mpl cytoplasmic domain and activation of the tyrosine kinase Jak2 leading to activation of several additional downstream signaling pathways. To examine the role of phosphorylation of cytoplasmic c-Mpl tyrosine residues in megakaryopoiesis and HSC survival signaling in vivo, we generated transgenic mice expressing the WT c-Mpl cDNA or a variant c-Mpl cDNA, with all 5 intracellular tyrosine residues mutated to phenylalanines. Expression of the transgenes was directed by a 2-kb Mpl promotor and both transgenic mice were crossed with mpl-/- mice to eliminate Mpl production from the native gene. In mice expressing the WT Mpl transgene (Y-ALL), platelet counts were rescued to levels that were 3-5fold higher than WT mice. Surprisingly, mice expressing the tyrosine deficient Mpl (F-ALL) also demonstrated similarly elevated platelet counts. However, plasma TPO levels in F-ALL mice were markedly elevated, and in Y-ALL mice they were comparable to WT levels. Therefore, the unexpected thrombocytosis found in F-ALL mice was hypothesized to be caused by a disruption in normal TPO homeostasis secondary to impaired receptor endocytosis and TPO degradation caused by mutations of the cytoplasmic tyrosines Y78 and Y8. Signal transduction by the F-ALL and Y-ALL transgenes was further studied in 32D cells, a cytokine dependent murine myeloid cell line. Although appropriately expressed on the cell surface, the tyrosine deficient Mpl protein showed absent Mpl tyrosine phosphorylation and greatly diminished Jak2 phosphorylation when stimulated with TPO. Nevertheless, F-ALL expressing 32D cells proliferated in response to TPO, though these cells required about 10fold higher ligand levels than Y-ALL expressing 32Ds to achieve maximum proliferation rates. To study the relative degrees of restoration of HSC and megakaryocyte compartments by Y-ALL and F-ALL transgenes, under conditions of intact TPO homeostasis, we performed competitive repopulation assays, transplanting Y-ALL or F-ALL marrow cells plus GFP expressing WT marrow cells into lethally irradiated recipients. Peripheral blood platelets in chimeras generated with F-ALL marrow were almost all produced by WT competitor cells. In contrast, in chimeras made with Y-ALL marrow >80% of platelet production was by Y-ALL cells. The percentage of peripheral leukocytes produced by each of the competitor donor cells was used as a surrogate of HSC activity. In contrast to the widely disparate contributions to megakaryopoiesis by Y-ALL and F-ALL marrow cells in chimeras, the rescue of HSC activity by each of these transgenes was comparable. Together, our data suggests that phosphorylation of intracellular tyrosine residues is critical in megakaryopoiesis but dispensable for TPO induced survival and proliferation signaling in HSCs. Either, the markedly reduced levels of Jak2 phosphorylation induced by TPO stimulation of the F-ALL transgene is adequate to support the HSC compartment or alternate Mpl signal transduction pathways that do not involve Jak2 are also involved. Disclosures: No relevant conflicts of interest to declare.


Endocrinology ◽  
2004 ◽  
Vol 145 (5) ◽  
pp. 2478-2486 ◽  
Author(s):  
T. Mushtaq ◽  
P. Bijman ◽  
S. F. Ahmed ◽  
C. Farquharson

Abstract The study aims were to improve our understanding of the mechanisms of glucocorticoid-induced growth retardation at the growth plate and determine whether IGF-I could ameliorate the effects. Fetal mouse metatarsals were cultured for up to 10 d with dexamethasone (Dex; 10–6m) and/or IGF-I and GH (both at 100 ng/ml). Both continuous and alternate-day Dex treatment inhibited bone growth to a similar degree, whereas IGF-I alone or together with Dex caused an increase in bone growth. GH had no effects. These observations may be explained at the cellular level; cell proliferation within the growing bone was decreased by Dex and increased by IGF-I and these effects were more marked in the cells of the perichondrium than those in the growth plate. However, the most prominent observation was noted in the hypertrophic zone where all treatments containing IGF-I significantly increased (3-fold) the length of this zone, whereas Dex alone had no significant effect. In conclusion, Dex impaired longitudinal growth by inhibiting chondrocyte proliferation, whereas IGF-I stimulated chondrocyte hypertrophy and reversed the growth-inhibitory Dex effects. However, the IGF-I-mediated improvement in growth was at the expense of altering the balance between proliferating and hypertrophic chondrocytes within the metatarsal.


2006 ◽  
Vol 21 (8) ◽  
pp. 1288-1296 ◽  
Author(s):  
Marie Kveiborg ◽  
Reidar Albrechtsen ◽  
Lise Rudkjaer ◽  
Guanmei Wen ◽  
Karen Damgaard-Pedersen ◽  
...  

Endocrinology ◽  
2005 ◽  
Vol 146 (6) ◽  
pp. 2501-2507 ◽  
Author(s):  
Ahmad Pazirandeh ◽  
Mikael Jondal ◽  
Sam Okret

Abstract We and others have previously reported that thymic epithelial cells produce glucocorticoids (GCs). In vitro studies have also suggested that thymic-derived GCs play a role in the development of thymocytes. However, until now it has not yet been established whether thymic-derived GCs play a role in thymopoiesis in vivo. To investigate this, we conditionally overexpressed the GC receptor (GR) in thymocytes using transgenic mice with a tetracycline-inducible expression system. The influence of systemic GCs was excluded by adrenalectomizing the transgenic mice before the GR induction. Conditional expression of transgenic GR in the thymocytes of adrenalectomized transgenic mice led to a decrease in the thymocyte number. This was associated with increased thymocyte apoptosis. The effect of thymic-derived GCs on the thymocytes was confirmed after transgenic GR induction in a thymic organ culture system. Finally, the GR antagonist RU486 increased thymocyte number in adrenalectomized mice in vivo and prevented a reduction in thymocyte number in thymic organ culture after transgenic GR induction. These observations further confirmed a role for the thymic-derived GCs in regulating thymocyte homeostasis in vivo.


2020 ◽  
Author(s):  
Ting-ting Yu ◽  
Qiu-fan Xu ◽  
Hui-jie Huang ◽  
Sarah Dugan ◽  
Lei Shao ◽  
...  

Abstract Background: Skeletal development and maintenance are complex processes known to be coordinated by multiple genetic and epigenetic signaling pathways. However, the role of long non-coding RNAs (lncRNAs), a class of crucial epigenetic regulatory molecules, has been under explored in skeletal biology. Results: Here we report a young patient with short stature, hypothalamic dysfunction and mild macrocephaly, who carries a maternally inherited 690kb deletion at Chr.1q24.2 encompassing a noncoding RNA gene, DNM3OS, embedded on the opposite strand in an intron of the DYNAMIN 3 (DNM3)gene. We show that lncRNA DNM3OS sustains the proliferation of chondrocytes independent of two co-cistronic microRNAs miR-199a and miR-214. We further show that nerve growth factor (NGF), a known factor of chondrocyte growth, is a key target of DNM3OS-mediated control of chondrocyte proliferation.Conclusion: This work demonstrates that DNM3OS is essential for preventing premature differentiation of chondrocytes required for bone growth through endochondral ossification.


2004 ◽  
Vol 180 (2) ◽  
pp. 247-255 ◽  
Author(s):  
J Wang ◽  
J Zhou ◽  
CM Cheng ◽  
JJ Kopchick ◽  
CA Bondy

The possibility that growth hormone (GH) has effects on long bone growth independent of insulin-like growth factor-I (IGF-I) has long been debated. If this is true, then long bone growth should be more profoundly affected by the absence of GH (since both GH and GH-stimulated IGF-I effects are absent) than by the absence of IGF-I alone (since GH is still present and actually elevated). To test this hypothesis, we compared long bone growth in mice with targeted deletions of Igf1 vs growth hormone receptor (Ghr). Tibial linear growth rate was reduced by approximately 35% in Igf1 null mice and by about 65% in Ghr null mice between postnatal days 20 and 40, a time of peak GH effect during normal longitudinal growth. The Igf1 null mouse growth plate demonstrated significant enlargement of the germinal zone; chondrocyte proliferation and numbers were normal but chondrocyte hypertrophy was significantly reduced. In contrast, the Ghr null mouse germinal zone was hypoplastic, chondrocyte proliferation and numbers were significantly reduced, and chondrocyte hypertrophy was also reduced. We have previously demonstrated that IGF-II is highly expressed in growth plate germinal and proliferative zones, so we considered the possibility that GH-stimulated IGF-II production might promote germinal zone expansion and maintain normal proliferation in the Igf1 null mouse growth plate. Supporting this view, IGF-II mRNA was increased in the Igf1 null mouse and decreased in the Ghr null mouse growth plate.Thus, in the complete absence of IGF-I but in the presence of elevated GH in the Igf1 null mouse, reduction in chondrocyte hypertrophy appears to be the major defect in longitudinal bone growth. In the complete absence of a GH effect in the Ghr null mouse, however, both chondrocyte generation and hypertrophy are compromised, leading to a compound deficit in long bone growth. These observations support dual roles for GH in promoting longitudinal bone growth: an IGF-I-independent role in growth plate chondrocyte generation and an IGF-I-dependent role in promoting chondrocyte hypertrophy. The question of whether GH has direct effects on chondrocyte generation is still not settled, however, since it now appears that IGF-II may medicate some of these effects on the growth plate.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Ting-ting Yu ◽  
Qiu-fan Xu ◽  
Si-Yang Li ◽  
Hui-jie Huang ◽  
Sarah Dugan ◽  
...  

Abstract Background Skeletal development and maintenance are complex processes known to be coordinated by multiple genetic and epigenetic signaling pathways. However, the role of long non-coding RNAs (lncRNAs), a class of crucial epigenetic regulatory molecules, has been under explored in skeletal biology. Results Here we report a young patient with short stature, hypothalamic dysfunction and mild macrocephaly, who carries a maternally inherited 690 kb deletion at Chr.1q24.2 encompassing a noncoding RNA gene, DNM3OS, embedded on the opposite strand in an intron of the DYNAMIN 3 (DNM3) gene. We show that lncRNA DNM3OS sustains the proliferation of chondrocytes independent of two co-cistronic microRNAs miR-199a and miR-214. We further show that nerve growth factor (NGF), a known factor of chondrocyte growth, is a key target of DNM3OS-mediated control of chondrocyte proliferation. Conclusions This work demonstrates that DNM3OS is essential for preventing premature differentiation of chondrocytes required for bone growth through endochondral ossification.


Sign in / Sign up

Export Citation Format

Share Document